NCT04818723View on ClinicalTrials.gov

Role of Montelukast in Preventing Relapse in Childhood Idiopathic Nephrotic Syndrome

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

May 30, 2020

Study Completion Date

May 30, 2020

Conditions
Nephrotic Syndrome
Interventions
DRUG

Montelukast

We wanted to know the role of leukotriene receptor antagonist (LTRA) montelukast in preventing relapses in idiopathic childhood nephrotic syndrome (NS)

Trial Locations (1)

Unknown

Department of Pediatric Nephrology, The Children's Hospital and Institute of Child Health, Multan

All Listed Sponsors
lead

Nishtar Medical University

OTHER

NCT04818723 - Role of Montelukast in Preventing Relapse in Childhood Idiopathic Nephrotic Syndrome | Biotech Hunter | Biotech Hunter